HeartVoice closes multimillion-yuan Pre-A financing round
On July 15, HeartVoice completed tens of millions of yuan in its Pre-A round of financing led by Zhongxin Zihe, Xinwen Capital.
On July 15, HeartVoice completed tens of millions of yuan in its Pre-A round of financing led by Zhongxin Zihe, Xinwen Capital. Proceeds from this round of funding will mainly be used for R&D iterations in the chip and cloud services business, brand construction and market expansion.
HeartVoice is a medical technology company dedicated to improving human heart health with artificial intelligence. The company was founded by a team of PhDs from the University of Science and Technology of China, Peking University and Huawei.
HeartVoice applies deep learning and other new-generation artificial intelligence technology to the field of ECG automatic analysis and diagnosis, and independently developed the world-leading Cardio-Learn® ECG analysis algorithm.
Currently, HeartVoice has provided heart health solutions to dozens of clients, covering areas such as 3A hospitals, primary care facilities, medical checkup centers, wearable device manufacturers, and smart home manufacturers.